Early cardiac rehabilitation after CABG with an upper-limb arm cycle versus standard arm exercises
Official title: Effects of Phase I Cardiac Rehabilitation With and Without Upper Limb Cycle Ergometer in Immediate Post-Operative Period of CABG
Run by Riphah International University · NCT07128849 · Data updated 2026-11-12
This project will test whether adding an upper-limb cycle ergometer to early rehab after CABG helps people with coronary artery disease recover better than standard arm exercises.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 65 Years |
| Sex | All |
| Enrollment | 44 (estimated) |
| Sponsor | Riphah International University Academic / other |
| Locations | 1 site (Lahore, Punjab Province) |
| Status | Recruiting |
| Started | July 17, 2025 |
| Main results expected | November 30, 2025 |
| Study ends | December 30, 2025 |
| Registry record updated | August 19, 2025 |
| Trial ID | NCT07128849 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are adults aged 40–65 with planned CABG who are hemodynamically stable, extubated, and able to perform upper-limb exercises without orthopedic or neurologic contraindications.
✕Probably not a fit
Patients with significant pulmonary disease, thyroid disorders, prolonged mechanical ventilation (>24 hours), unstable blood pressure or heart rate, orthopedic or neurologic limitations, intra-aortic balloon use, or major postoperative complications are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized clinical trial enrolls adults after coronary artery bypass grafting and compares phase I cardiac rehabilitation that includes an upper-limb cycle ergometer to the same rehab program without the ergometer. Participants are recruited in the immediate postoperative, post-extubation period and must be hemodynamically stable and able to perform upper-limb activity. Outcomes include quality of life, dyspnea, functional measures, cardiovascular parameters, and upper-limb strength and range of motion. The trial is conducted at a Lahore hospital affiliated with the sponsoring university using convenience sampling of eligible CABG patients.
Why it matters
Potential benefit: If successful, adding arm-ergometer sessions could speed recovery by improving upper-limb strength, mobility, breathing symptoms, and overall functional recovery after CABG.
How similar studies have gone: Prior small rehabilitation studies and reports have shown that arm ergometry can improve upper-limb strength, function, and psychosocial outcomes, but randomized data in immediate post-CABG phase I settings are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Planned CABG patients * 40-65 years * Both male and female * Hemodynamic stable patients * Post extubation Exclusion Criteria: * Patients suffering from pulmonary diseases and thyroid disorders * Mechanical ventilation more than 24 hr * Mean arterial pressure i.e, \< 60 mmHg or \> 140 mmHg and heart rate not more than 120bpm * Having an orthopedic condition that makes the use of upper and lower extremity impossible. * Who have neurological impairment influencing breathing rate and heart rate. * Who required the implantation of an intra-aortic balloon during surgery * Who experienced postoperative complications such as pulmonary embolism
Where it's running
-
Gulab Devi Hospital
Lahore, Punjab Province, Pakistan Recruiting
Study contacts
- Principal investigator: Iram Nawaz, Mphill — Riphah International University
- Study coordinator: imran amjad, Phd
- Email: imran.amjad@riphah.edu.pk
- Phone: 03324390125
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SiroMax sirolimus-coated balloon for small coronary vessels with or without prior stents
A first-in-human test to see if the SiroMax drug-coated balloon can safely open narrow coronary arteries in adults with or without prior stents.
-
Lidocaine added to Custodiol for heart protection during CABG
This trial will test whether adding lidocaine to Custodiol reduces ventricular arrhythmias and the need for defibrillation in adults having elective on‑pump coronary artery bypass grafting.
-
AI platform for CT coronary angiography applications
This study is testing a new AI platform that helps doctors quickly and accurately analyze heart scans for patients with coronary artery disease to improve their treatment and care.
-
Testing a new low energy MRI scanner for heart imaging
This study is testing a new low-energy MRI scanner to see if it can create better heart images safely for both healthy people and those with heart disease, including those with metal implants.
-
Red grape juice and metabolism in men with coronary disease
Researchers will test whether daily red grape juice changes the blood metabolite profile in men with chronic coronary artery disease.
-
Edoxaban vs. Apixaban in AF with CAD: Net Benefit
This trial tests whether edoxaban-based therapy provides a similar or better overall benefit than apixaban-based therapy for stroke prevention and major bleeding in adults with atrial fibrillation and coronary artery disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.